FDA okays start of BrainStorm stem cell trial in ALS patients – Reuters India
|
FDA okays start of BrainStorm stem cell trial in ALS patients
Reuters India “Today’s announcement represents the most significant milestone BrainStorm has achieved to date,” the company’s president, Chaim Lebovits, said. This trial will be the first Phase II double-blinded stem cell study to be conducted for ALS, he added. ALS … |
